Related Experiment Video
Updated: Jun 23, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes
M Rivet-Bastide1, G Vandecasteele, S Hatem
1Laboratoire de Cardiologie Cellulaire et Moléculaire, Institut National de la Santé et de la Recherche Médicale U-446, Université de Paris-Sud, Faculté de Pharmacie, F-92296 Châtenay-Malabry, France.
Insights
Erythro-9-[2-hydroxy-3-nonyl]adenine (EHNA) enhances cardiac L-type Ca2+ current in human atrial cells by inhibiting phosphodiesterase 2 (PDE2). This suggests PDE2 regulates basal Ca2+ influx in these cells.
Area of Science:
- Cardiovascular Physiology
- Molecular Pharmacology
- Cell Signaling
Background:
- Erythro-9-[2-hydroxy-3-nonyl]adenine (EHNA) is a known inhibitor of adenosine deaminase.
- Recent studies identified EHNA as an inhibitor of phosphodiesterase 2 (PDE2) with a Ki of approximately 1 microM.
- EHNA showed negligible effects on other PDE isozymes like PDE1, PDE3, and PDE4.
Purpose of the Study:
- To investigate the role of PDE2 in regulating cardiac L-type Ca2+ current (ICa) in human atrial myocytes.
- To determine if EHNA's effect on ICa is mediated by PDE2 inhibition.
Main Methods:
- Freshly isolated human atrial myocytes were used to examine the effect of EHNA on ICa.
- Electrophysiological recordings were performed to measure changes in ICa amplitude and kinetics.
- Experiments included varying EHNA concentrations, using other PDE inhibitors, and manipulating intracellular cyclic nucleotide levels.
Main Results:
- EHNA (0.1-10 microM) significantly increased basal ICa amplitude in human atrial myocytes by approximately 80% at 1 microM.
- EHNA did not alter current-voltage or inactivation curves, and its effect was not additive with isoprenaline.
- The effect was specific to PDE2 inhibition, as other adenosine deaminase inhibitors or adenosine did not affect ICa, and EHNA was ineffective in rat myocytes.
Conclusions:
- Basal cardiac L-type Ca2+ current in human atrial myocytes is regulated by PDE2 activity.
- PDE2 inhibition by EHNA leads to increased ICa, suggesting a role in controlling intracellular cyclic nucleotide levels.
- Both PDE2 and PDE3 may contribute to maintaining low cyclic nucleotide concentrations in the absence of cyclase stimulation.
Abstract:
EHNA (Erythro-9-[2-hydroxy-3-nonyl]adenine) is a wellknown inhibitor of adenosine deaminase. Recently, EHNA was shown to block the activity of purified soluble cGMPstimulated phosphodiesterase (PDE2) from frog, human, and porcine heart with an apparent Ki value of approximately 1 microM and with negligible effects on Ca2+/calmodulin PDE (PDE1), cGMP-inhibited PDE (PDE3), and low Km cAMP-specific PDE (PDE4) (Méry, P.F., C. Pavoine, F. Pecker, and R. Fischmeister. 1995. Mol. Pharmacol. 48:121-130; Podzuweit, T., P. Nennstiel, and A. Muller. 1995. Cell. Signalling. 7:733- 738). To investigate the role of PDE2 in the regulation of cardiac L-type Ca2+ current (ICa), we have examined the effect of EHNA on ICa in freshly isolated human atrial myocytes. Extracellular application of 0.1-10 microM EHNA induced an increase in the amplitude of basal ICa ( approximately 80% at 1 microM) without modification of the current-voltage or inactivation curves. The maximal stimulatory effect of EHNA on ICa was comparable in amplitude with the maximal effect of isoprenaline (1 microM), and the two effects were not additive. The effect of EHNA was not a result of adenosine deaminase inhibition, since 2'-deoxycoformycin (1-30 microM), another adenosine deaminase inhibitor with no effect on PDE2, or adenosine (1-10 microM) did not increase ICa. In the absence of intracellular GTP, the substrate of guanylyl cyclase, EHNA did not increase ICa. However, under similar conditions, intracellular perfusion with 0.5 microM cGMP produced an 80% increase in ICa. As opposed to human cardiomyocytes, EHNA (1-10 microM) did not modify ICa in isolated rat ventricular and atrial myocytes. We conclude that basal ICa is controlled by PDE2 activity in human atrial myocytes. Both PDE2 and PDE3 may contribute to keep the cyclic nucleotides concentrations at minimum in the absence of adenylyl and/or guanylyl cyclase stimulation.
More Related Videos
10:46Mechanical Stimulation-induced Calcium Wave Propagation in Cell Monolayers: The Example of Bovine Corneal Endothelial Cells
Published on: July 16, 2013
06:22Isolation of High Quality Murine Atrial and Ventricular Myocytes for Simultaneous Measurements of Ca2+ Transients and L-Type Calcium Current
Published on: November 3, 2020
Related Concept Videos
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...